Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Ectasia of Cornea: full-pipeline trial registry

2 of 2 indexed Ectasia of Cornea trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Ectasia of Cornea: 2 US clinical trials tracked, 2 recruiting.

Ectasia of Cornea is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Pacific Clear Vision Institute, running 1 of these trials.

Enrollment posture brief

Registry condition ectasia-of-cornea

OPEN 2 | RECR 100% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Ectasia of Cornea (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Ectasia of Cornea

Ectasia of Cornea lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ectasia of Cornea on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ectasia of Cornea is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Named interventions

Most-linked intervention names on Ectasia of Cornea records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution Combination
1 trials
Epi-ON corneal cross-linking Combination
1 trials

US sites by state

Facility locations filed on Ectasia of Cornea trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Oregon 1 trials
North Carolina 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ectasia of Cornea page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ectasia of Cornea condition card totals 2 registered trials; most-linked intervention PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.